Suppr超能文献

肌球蛋白诱导的上皮-间充质转化抑制高转移性结直肠癌的生长。

Epithelial-mesenchymal transition induced by MyoD inhibits growth of high metastatic colorectal cancer.

机构信息

Department of General Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China.

Digestive Department, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China.

出版信息

Med Hypotheses. 2019 Sep;130:109285. doi: 10.1016/j.mehy.2019.109285. Epub 2019 Jun 24.

Abstract

OBJECTIVES

The study aimed to investigate the tumor-suppressing factor myogenicity differentiation factor (MyoD) against high metastatic colorectal cancer through its powerful transformation by which the tumor cells were converted into muscle cells or other cells to inhibit the malignant proliferation of tumor cells.

METHODS

The roles of MyoD in colon cancer proliferation, invasion and migration were analyzed by CCK-8 assay and Transwell, and EMT by real-time PCR and Western blot. The secretion of TGFβ1 was assayed by ELISA and activation of p-Smad2/3 were assayed by western blot. The effects of MyoD on intestinal cancer growth and EMT in vivo were also analyzed.

RESULTS

We found MyoD inhibited the proliferation, invasion and migration of colon cancer cell. Moreover, MyoD inhibited the expression of E-cadherin and promoted the expression of vimentin and α-SMA. The secretion of TGFβ1 increased and p-Smad2/3 was activated after MyoD expression. MyoD also inhibits intestinal cancer growth and promoted EMT in vivo.

CONCLUSION

Our findings indicate that MyoD inhibited cancer progression and metastasis by promoting EMT through TGF-β1/Smad2/3 activation, which provide new support for MyoD maybe as a novel anti-cancer method for the treatment of colon cancer in the future.

摘要

目的

本研究旨在通过肌源性分化因子(MyoD)的强大转化作用,将肿瘤细胞转化为肌肉细胞或其他细胞,从而抑制肿瘤细胞的恶性增殖,研究 MyoD 对高转移性结直肠癌的肿瘤抑制因子作用。

方法

通过 CCK-8 检测和 Transwell 分析 MyoD 在结肠癌细胞增殖、侵袭和迁移中的作用,通过实时 PCR 和 Western blot 分析 EMT,通过 ELISA 检测 TGFβ1 的分泌,通过 Western blot 检测 p-Smad2/3 的激活。还分析了 MyoD 对体内肠癌生长和 EMT 的影响。

结果

我们发现 MyoD 抑制结肠癌细胞的增殖、侵袭和迁移。此外,MyoD 抑制 E-钙黏蛋白的表达,促进波形蛋白和α-SMA 的表达。MyoD 表达后 TGFβ1 分泌增加,p-Smad2/3 被激活。MyoD 还抑制体内肠癌的生长和 EMT。

结论

我们的研究结果表明,MyoD 通过激活 TGF-β1/Smad2/3 促进 EMT 抑制癌症进展和转移,为 MyoD 可能作为未来结肠癌治疗的一种新的抗癌方法提供了新的支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验